Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
2015
MEK1/2 inhibitors in the treatment of gynecologic malignancies
2014
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
2014 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
n−3 Fatty acids and the metabolic syndrome
2006
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
MEK in cancer and cancer therapy
2013
Transient MEK inhibitor-associated retinopathy in metastatic melanoma
2014
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
2010 StandoutNobel
The metabolic syndrome
2010 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: A health technology assessment report
2010
Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis
2014
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
C‐reactive protein and coronary heart disease: a critical review
2008
Immunotherapeutic Approaches for Alzheimer’s Disease
2015
RAS-targeted therapies: is the undruggable drugged?
2020
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk Markers
2006
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Beyond High-Density Lipoprotein Cholesterol Levels
2008
Lipoprotein Management in Patients With Cardiometabolic Risk
2008
Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation
2007
Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature‐based meta‐analysis of prospective studies
2006
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
2006
Combination statin–fibrate therapy: safety aspects
2008
Non‐High‐Density Lipoprotein Cholesterol: An Alternate Target for Lipid‐Lowering Therapy
2004
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
2007 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
The metabolic syndrome—a new worldwide definition
2005 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Prospects for MEK inhibitors for treating cancer
2014
Cholesteryl Ester Transfer Protein in Metabolic Syndrome
2006
Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B–containing lipoproteins
2008 StandoutNobel
Cardiovascular Disease Under the Influence of Excess Visceral Fat
2007
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
2006
Apolipoprotein A1 and B
2006
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
2008
MEK Inhibition in the Treatment of Advanced Melanoma
2013
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study
2007
Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome
2004
Relationship of pericardial fat with lipoprotein distribution: The Multi-Ethnic study of atherosclerosis
2015
Cardiac Remodeling in Obesity
2008
Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm
2004
Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program
2014
Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice
2008 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Improving Prospects for Targeting RAS
2015
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
2009
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Comparison of the Associations of Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study
2004
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
2009
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Triglyceride to HDL-C Ratio and Increased Arterial Stiffness in Children, Adolescents, and Young Adults
2013
A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
2011
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
The Metabolic Syndrome
2008 Standout
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
2007 Standout
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
2016
Lipids and Lipoproteins in Patients With Type 2 Diabetes
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
Genetic Loci Influencing C-reactive Protein Levels and Risk of Coronary Heart Disease
2009
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease
2006
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Annie St‐Pierre being referenced
Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases
2011
The Triglyceride/High-Density Lipoprotein Cholesterol Ratio, the Small Dense Low-Density Lipoprotein Phenotype, and Ischemic Heart Disease Risk
2004
Inflammatory markers and long-term risk of ischemic heart disease in men
2005
Effect of Plasma C-Reactive Protein Levels in Modulating the Risk of Coronary Heart Disease AssociatedWith Small, Dense, Low-Density Lipoproteins in Men(The Quebec Cardiovascular Study)
2003
Apolipoprotein-B, Low-Density Lipoprotein Cholesterol, and the Long-Term Risk of Coronary Heart Disease in Men
2006
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
2013
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk
2003
Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men
2004